1Y Annualised Return
▲155.93%
3Y Annualised Return
▲194.99%
5Y Annualised Return
▲179.56%
Shukra Pharmaceuticals Stock Performance
|
|
|
Shukra Pharmaceuticals Company background
Founded in: 1993
Managing director: Dakshesh Shah
Shukra Pharmaceuticals Limited (Formerly known Relish Pharmaceuticals Limited) was established in March, 1993 and later on the Company name was changed from Relish Pharmaceuticals Limited to Shukra Pharmaceuticals Limited effective on September 22, 2016. The Company is presently engaged in the business of manufacturing and trading of pharmaceuticals formulations and laboratory testing. The company provides varieties of products to the clientele. Their product portfolio includes Antibiotics (Penicillin), Anti Biotics (Cephalosporin), Anti Biotics, Macrolides, Quinolones, Anti Bacterial, Anti Fungal, Anti Malarial, Anti Viral, Anti Protozoal, Anti Anthelmintic, Sedative and Tranquilliser, Anti Depressant, Anti Manic, Anti Emetic, Anti Ulcer, Beta Blockers, Diuretics, Analgesic, Analgesic (NASID), Muscle Relaxants, Anti Tuberculosis, Vitamin Products, Anti Allergics, Corticosteroids, Hyper and Hypoglycemic, Others.The company has four manufacturing divisions namely tablets (General and Beta Lactum) Capsules (General and Beta Lactum), Liquid and small volume parental. Their manufacturing unit is located at Rakanpur in Gujarat.The company customers include leading Manufacturers like Cadila Healthcare Limited (Zydus), Intas Pharmaceuticals Limited, Cadila Pharmaceuticals Limited, Makers Laboratories Limited, Agenta Pharma Limited etc.The company has assisted in the development and manufacture of a wide variety of drugs and dosage forms and potency variations for many prestigious pharmaceuticals companies around the world.In FY 201314, the Company got approval from Honble High Court of Gujarat for revival of Relish Pharmaceuticals Limited and Amalgamation of Proper Dealcomm Private Limited with the erstwhile Relish Pharmaceuticals Limited and Reorganization of Share Capital of Relish Pharmaceuticals Limited through the Scheme of Arrangement vide Honble High Court of Gujarat order dated 20 December, 2013.
As of , Shukra Pharmaceuticals share price is ₹21.6. The stock opened at ₹22.4 and had closed at ₹22 the previous day. During today’s trading session, Shukra Pharmaceuticals share price moved between ₹21.57 and ₹22.45, with an average price for the day of ₹22.01. Over the last 52 weeks, the stock has recorded a low of ₹5.75 and a high of ₹27.15. In terms of performance, Shukra Pharmaceuticals share price has increased by 6% over the past six months and has increased by 155.93% over the last year.
Shukra Pharmaceuticals SIP Return Calculator
Over the past
1 year
3 years
5 years
Total Investment of ₹65,00,000
Would have become ₹1,56,56,132 (+140.86%)
Daily SIP of ₹25,000 would have become ₹1,56,56,132 in 1 year with a gain of ₹91,56,132 (+140.86%)
Shukra Pharmaceuticals Fundamental
Market Cap (in crs)
944.51
Face Value
1
Turnover (in lacs)
91.63
Key Metrics
Qtr Change %
275.13% Gain from 52W Low
10.6
Dividend yield 1yr %
Below industry Median
0.5
Shukra Pharmaceuticals Technical Analysis
Moving Averages Analysis
Moving Averages Analysis
0.00
Current Price
5Day EMA
21.30
10Day EMA
20.20
12Day EMA
19.80
20Day EMA
18.50
26Day EMA
17.80
50Day EMA
16.90
100Day EMA
16.60
200Day EMA
15.10
5Day SMA
21.40
10Day SMA
20.40
20Day SMA
17.50
30Day SMA
16.40
50Day SMA
15.20
100Day SMA
17.80
150Day SMA
17.80
200Day SMA
15.10
Delivery & Volume
| Period | Combined Delivery Volume | NSE+BSE Traded Volume |
|---|---|---|
Day Rs | 424804 Rs | 424804 Rs |
Week Rs | 193506 Rs | 193506 Rs |
Month Rs | 205923 Rs | 205923 Rs |
Resistance & Support
21.86
Pivot
Resistance
First Resistance
22.16
Second Resistance
22.74
Third Resistance
23.04
Support
First Support
21.28
Second support
20.98
Third Support
20.40
Relative Strength Index
82.06
Money Flow Index
87.32
MACD
1.97
MACD Signal
1.51
Average True Range
0.57
Average Directional Index
43.91
Rate of Change (21)
59.78
Rate of Change (125)
8.09
Shukra Pharmaceuticals Peer comparison
| Index Name | Market Price | Market Cap | 52W Low | 52W High | Prev. Close | 1W Return | 1M Return | 6M Return | 1Y Return | 3Y Return | Dividend Yield | PE Ratio | Industry PE | PB Ratio |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
- | 859.58 | 155 | 369.7 | 180.59 | 0.00% | -6.54% | -9.99% | -28.30% | -13.39% | 1.68% | 32.03 | 43.87 | 1.99 | |
274.15 | 274.15 | - | - | - | - | - | - | - | - | - | - | - | - | |
- | 945.41 | 74.25 | 122.85 | 99.71 | -8.38% | -9.77% | -7.86% | 0.00% | 0.00% | 0.79% | 20.00 | 43.87 | 2.90 | |
- | 1,094.83 | 212.05 | 449 | 370.80 | -3.24% | 13.54% | -5.68% | 60.10% | 93.70% | 0.00% | 16.20 | 43.87 | 2.88 | |
- | 850.12 | 957 | 2755.1 | 1,400.50 | 5.58% | 37.84% | -17.32% | -47.41% | -22.94% | 0.00% | 46.82 | 43.87 | 3.04 | |
- | 1,086.35 | 802 | 1870 | 1,640.90 | 10.42% | 37.54% | 14.19% | 4.04% | 374.85% | 0.06% | 41.07 | 43.87 | 2.81 |
Shukra Pharmaceuticals Share Price FAQs
How to buy Shukra Pharmaceuticals shares?
You can easily buy Shukra Pharmaceuticals shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.
What is the 52-week high and low of Shukra Pharmaceuticals ?
The 52-week high and low of Shukra Pharmaceuticals share price is ₹27.15 and ₹5.75 as of 18/7/2025.
Please be aware that Shukra Pharmaceuticals stock prices are subject to continuous fluctuations due to various factors.
Open Demat Account